AstraZeneca PLC (AZN.L)
AZN.L on London Stock Exchange
5,815.00GBp
18 Apr 2019
5,815.00GBp
18 Apr 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
5,815.00
5,815.00
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
2,160,249
2,160,249
52-wk High
6,540.00
6,540.00
52-wk Low
4,928.50
4,928.50
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.76 | December | 23 Apr 2019 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 7 | 7 | 7 | 7 |
| (2) OUTPERFORM | 10 | 10 | 10 | 9 |
| (3) HOLD | 6 | 7 | 7 | 9 |
| (4) UNDERPERFORM | 1 | 2 | 2 | 2 |
| (5) SELL | 1 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.16 | 2.15 | 2.15 | 2.22 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 9 | 5,651.24 | 5,863.00 | 5,460.00 | 5,527.68 |
| Quarter Ending Sep-19 | 9 | 5,995.91 | 6,223.00 | 5,725.50 | 6,197.14 |
| Year Ending Dec-19 | 24 | 23,512.20 | 24,255.00 | 22,578.00 | 23,951.10 |
| Year Ending Dec-20 | 26 | 25,963.30 | 28,421.00 | 24,249.40 | 26,273.40 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 7 | 0.76 | 0.82 | 0.70 | 1.04 |
| Quarter Ending Sep-19 | 7 | 0.97 | 1.08 | 0.85 | 0.94 |
| Year Ending Dec-19 | 26 | 3.58 | 4.16 | 3.21 | 3.98 |
| Year Ending Dec-20 | 26 | 4.30 | 5.01 | 3.46 | 4.83 |
| LT Growth Rate (%) | 3 | 12.48 | 19.60 | 3.75 | 5.21 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Dec-18 | 6,385.64 | 6,417.00 | 31.36 | 0.49 |
| Quarter Ending Sep-18 | 5,302.97 | 5,340.00 | 37.03 | 0.70 |
| Quarter Ending Jun-18 | 4,822.20 | 5,155.00 | 332.80 | 6.90 |
| Quarter Ending Mar-18 | 5,282.61 | 5,178.00 | 104.61 | 1.98 |
| Quarter Ending Dec-17 | 5,473.40 | 5,777.00 | 303.60 | 5.55 |
| Earnings (per share) | ||||
| Quarter Ending Dec-18 | 1.43 | 1.58 | 0.15 | 10.14 |
| Quarter Ending Sep-18 | 0.70 | 0.71 | 0.01 | 1.00 |
| Quarter Ending Jun-18 | 0.71 | 0.69 | 0.02 | 2.69 |
| Quarter Ending Mar-18 | 0.60 | 0.48 | 0.12 | 20.19 |
| Quarter Ending Dec-17 | 0.84 | 1.30 | 0.46 | 54.91 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-19 | 5,651.24 | 5,648.40 | 5,582.87 | 5,578.02 | 5,527.68 |
| Quarter Ending Sep-19 | 5,995.91 | 5,987.32 | 5,915.86 | 5,905.63 | 6,197.14 |
| Year Ending Dec-19 | 23,512.20 | 23,504.70 | 23,514.70 | 23,492.90 | 23,951.10 |
| Year Ending Dec-20 | 25,963.30 | 25,945.80 | 25,947.40 | 25,877.90 | 26,273.40 |
| Earnings (per share) | |||||
| Quarter Ending Jun-19 | 0.76 | 0.77 | 0.77 | 0.77 | 1.04 |
| Quarter Ending Sep-19 | 0.97 | 0.97 | 0.95 | 0.96 | 0.94 |
| Year Ending Dec-19 | 3.58 | 3.60 | 3.65 | 3.65 | 3.98 |
| Year Ending Dec-20 | 4.30 | 4.32 | 4.44 | 4.48 | 4.83 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jun-19 | 2 | 2 | 4 | 3 |
| Quarter Ending Sep-19 | 3 | 1 | 5 | 2 |
| Year Ending Dec-19 | 2 | 2 | 6 | 11 |
| Year Ending Dec-20 | 4 | 1 | 12 | 5 |
| Earnings | ||||
| Quarter Ending Jun-19 | 1 | 1 | 1 | 4 |
| Quarter Ending Sep-19 | 2 | 1 | 3 | 2 |
| Year Ending Dec-19 | 0 | 5 | 1 | 18 |
| Year Ending Dec-20 | 0 | 5 | 0 | 17 |
Earnings vs. 
Estimates- UPDATE 2-European shares rise as short covering, earnings help temper tepid PMIs
- FTSE 100 dips on sluggish euro zone PMI, Unilever sparkles
- UPDATE 2-FTSE 100 dips on sluggish euro zone PMI, Unilever sparkles
- Banks, pharma drag FTSE 100 but Unilever cheery on strong quarter
- London's shares off six-month highs, Bunzl suffers worst day in a decade
- What does AstraZeneca plc's deal with Pfizer mean for shareholders?
- Is Hikma Pharmaceuticals plc the best FTSE 100 healthcare stock to own after today’s update?
- 3 stocks to help you retire early
- Is it time to take profits on GlaxoSmithKline plc and AstraZeneca plc?
- These FTSE 100 stars have exploded in Q3! And they're not finished yet
- Why now is the perfect time to buy these 3 super income stocks